Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $807.94M Activated in VL: True Average Daily Range Avg Daily Range: $1.04 | 2.93% Avg Daily Range (30 D): $0.35 | 3.07% Avg Daily Range (90 D): $0.24 | 2.45% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 1.84M Avg Daily Volume (90 D): 1.82M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 95 Institutional Trades Total Inst.Trades: 3,185 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.85M Avg Inst. Trade (90 D): $1.97M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $2.15M Avg Closing Trade (90 D): $1.99M Avg Closing Volume: 90.12K     News Dec 6, 2025 @ 1:05 PM Arvinas Presents Preclinical Data Supporting Mecha... Source: Arvinas, Inc. Nov 24, 2025 @ 12:00 PM Arvinas Announces Data Presentations from the Vepd... Source: Arvinas, Inc. Nov 3, 2025 @ 9:00 PM Arvinas to Present Preclinical Data for ARV-393 at... Source: Arvinas, Inc. Oct 24, 2025 @ 8:00 PM Arvinas Presents Preclinical Data for ARV-806 Demo... Source: Arvinas, Inc. Oct 22, 2025 @ 8:00 PM Arvinas to Present Preclinical Data for ARV-806, a... Source: Arvinas, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.48 $-.84 Diluted EPS $-.48 $-.84 Revenue $ $ 41.9M $ 22.4M Gross Profit $ $ $ Net Income / Loss $ $ -35.1M $ -61.2M Operating Income / Loss $ $ -43.8M $ -71.5M Cost of Revenue $ $ $ Net Cash Flow $ $ -13.4M $ 33.9M PE Ratio